India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are revolutionising India’s medical future.
While pharmaceutical sector faces pressure because of US tariff uncertainty, Laboratory stocks are gradually recovering and gaining strength. These stocks…